Table 1.
Relationship Between PCAT6 Expression and Clinicopathological Parameters of Patients With Lung Cancer
| Characteristics | Number (N = 58) | Relative PCAT6 Expression | ||
|---|---|---|---|---|
| Low | High | p-Value (Chi-Square Test) | ||
| Age (years) | 1.00 | |||
| ≤60 | 26 | 14 | 12 | |
| >60 | 32 | 17 | 15 | |
| Gender | 0.7919 | |||
| Male | 32 | 18 | 14 | |
| Female | 26 | 13 | 13 | |
| Differentiation | 0.4342 | |||
| Well/moderate | 33 | 16 | 17 | |
| Poor | 25 | 15 | 10 | |
| Tumor size | 0.0343 | |||
| ≤3 cm | 39 | 20 | 9 | |
| >3 cm | 19 | 11 | 18 | |
| Smoking history | 0.5884 | |||
| Ever | 37 | 21 | 16 | |
| Never | 21 | 10 | 11 | |
| Lymph node metastasis | <0.0001 | |||
| Positive | 36 | 11 | 25 | |
| Negative | 22 | 20 | 2 | |
| TNM stage | 0.018 | |||
| I | 25 | 18 | 7 | |
| II/III/IV | 33 | 13 | 20 | |
To discriminate patients with low or high PCAT6 expression, cutoff point value is 15.08.